Singapore
The secondaries investor is engaging with GPs on CVs as capital-raising tools for trophy assets.
1
Circle's shares triple in NYSE debut lifting IPO market rebound hopes
2
Chinese ride-hailing company Didi Global reports 8.5% revenue rise in Q1
3
SEC takes aim at China, moves to toughen rules for US-listed foreign firms
4
Asian companies in talks to list in Saudi Arabia, says exchange CEO
5
Credit Suisse, SoftBank spar over Greensill losses in $440m London lawsuit
More Stories
Dymon Asia plots sale of Texas Chicken’s Singapore-based parent Select Group
Singapore insurtech bolttech closes Series C round at $147m
Carlyle said to have joined investors circling Starbucks China stake
Singapore robo advisor Syfe closes Series C round at $80m
Philippine fintech BillEase leverages profitability to tap local financing
Rest of Asia
International investors are playing a significant role in educating Japanese GPs.
The firm is in discussions with GPs who have high-quality assets in India, Australia, and Japan.
The volume of high-quality opportunities has surged, said Adeline Tan, Head of Investments for Asia.
The shifting view could lead to LPs diverting some of their capital to Asian economies.
Greater China
Both LPs and GPs asserted that there’s no market besides the US that is as substantial as China.
Secondaries offer diversified exposure, faster liquidity, and better asset visibility.
Asia-based LPs are increasingly receptive to private market allocations.
The firm will continue to look at the US market, but in a selective manner.
World
However, AI cannot replace the need for people-to-people engagement in the deal process.
Sign up now and claim 10% off your first subscription. Use code "DSAWELCOME10" and step into Asia’s top dealmaking intelligence platform.
